What We Do

The Challenge

Medical products and related pharmaceutical services play a decisively large role in determining health outcomes. With the challenges prevalent in low- and middle-income countries, such as high out-of-pocket expenses for medicines and substandard and falsified products, success with treatments for common diseases is gravely impeded. Access to safe and quality medicines at an affordable price and their responsible use by all populations can help countries prevent maternal and child deaths, create an AIDS-free generation, and protect their communities from infectious disease threats.

Further, ensuring appropriate use of medical products can help control antimicrobial resistance, a growing global threat that is making infections harder to treat.

MTaPS Goal

Funded by the US Agency for International Development (USAID) and implemented by a consortium led by Management Sciences for Health (MSH), MTaPS aims to help low- and middle-income countries strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medicines and pharmaceutical services.

The five-year program builds upon the work of its predecessor program, the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS).

View or download MTaPS Program factsheet

Pharmaceutical Systems Strengthening (PSS) Technical Areas

  • Governancelist homeGovernance Strengthening pharmaceutical-sector governance
  • Institutional Regulatory Systems Strengthening national regulatory systems and supporting regional and continental harmonization
  • InformationCapacity Building Increasing institutional and human resource capacity for pharmaceutical management and services
  • FinancingInformation Systems Increasing the availability and use of pharmaceutical information for decision making

Health Areas

Sustainable access to safe, effective and quality-assured medicines and their appropriate use by all populations are key to eliminating epidemics and preventing avoidable deaths. MTaPS works with countries in the following health areas to drive better health outcomes in a sustained way:

Supporting the Global Health Security Agenda

As a core part of its work, USAID MTaPS supports USAID’s efforts under the Global Health Security Agenda (GHSA) to combat antimicrobial resistance (AMR), a growing threat to the efficacy of treatments worldwide. Meeting the MTaPS objective of improving pharmaceutical services to achieve health outcomes, these efforts are directed toward building countries’ capacities to optimize their use of antimicrobials and avert infectious disease threats – thus securing health nationally and globally.

Program Related Resources

resource-tags-1028

Covid-19 Monthly Report January 2021

Published : February 16, 2021

This report provides an update on USAID MTaPS’ response against the COVID-19 pandemic. The report describes the activities implemented, their status, and progress by country for […]

Read More
resource-tags-1253

E-learning Courses on Infection Prevention and Control

Published : July 30, 2020

Preventing and controlling the spread of infectious diseases is key to protecting the health of both patients and health care workers. This is an urgent need […]

Read More
resource-tags-1380

Recommended precautions for household members, intimate partners, and caregivers in a nonhealthcare setting of a patient with confirmed or suspected COVID-19

Published : April 6, 2020

Household members, intimate partners, and caregivers in a nonhealthcare setting may have close contact with a person with symptomatic, laboratory-confirmed COVID-19 or a person under investigation. […]

Read More